Life Science 2030

Our experience of operating in this market for many decades demonstrates enormous change. Oxford and Cambridge strength in the life science sector has been driven by growing ecosystems of global corporates, start-ups and expanding SMEs working across a range of highly specialist areas. We have seen how the rapid developments in life sciences and associated technology sectors have translated to significant real estate implications.

The coming decade will see a further acceleration across the life science sector, with technological and scientific advances across specialisations, from biopharmaceuticals, medical technology, diagnostics and digital heath. 

Given the evolution we at Bidwells have witnessed over the last decade, we’re clear that we should not underestimate the changes we will see over the coming 10 years, with the inevitable implications for the physical real estate, location decision making and ultimately the characteristics of investment asset.

Given this, we are in the midst of a programme of work Life Science 2030 – the implications for real estate. We look forward to discussing this work with our clients over the coming months, but in the meantime, we will be publishing a series of short blogs highlighting some of the issues we are considering.